|
2008 Conference Publication The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipientsKaisar, M., Armstrong, K., Prins, J., Marwick, T., Johnson, D., Hawley, C. and Isbel, N. (2008). The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology , Newcastle, Australia, 6–10 September 2008. Hoboken, NJ United States: Wiley-Blackwell. |
|
2008 Conference Publication Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injuryGobe, G., Bennett, N., Patel, J., Yamada, M., Colditz, P. and Johnson, D. (2008). Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Carlton, Australia: Blackwell. doi: 10.1111/j.1440-1797.2008.001013.x |
|
2008 Conference Publication Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesityPercy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2008). Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. OXFORD: BLACKWELL PUBLISHING. |
|
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney diseaseGobe, GC, Vesey, DA, Bennett, NC and Johnson, DW (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x |
|
2008 Conference Publication Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injuryGobe, G., Bennett, N., Patel, J., Yamada, M., Colditz, P. and Johnson, D. (2008). Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Hoboken, NJ, United States: Wiley-Blackwell. |
|
2008 Journal Article The role of novel biomarkers of cardiovascular disease in chronic kidney disease: Focus on adiponectin and leptinKaisar, Omar M., Johnson, David W., Prins, Judith B. and Isbel, Nicole (2008). The role of novel biomarkers of cardiovascular disease in chronic kidney disease: Focus on adiponectin and leptin. Current Cardiology Reviews, 4 (4), 287-292. doi: 10.2174/157340308786349516 |
|
2008 Conference Publication Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageingPercy, Christine, Brown, L., Johnson, D. W. and Gobe, G. (2008). Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageing. Australian and New Zealand Society of Nephrology (ANZSN) Annual Conference, Newcastle, Australia, 6-10 September 2008. |
|
2007 Journal Article Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathwayLi, Jun, Vesey, David A., Johnson, David W. and Gobe, Glenda C. (2007). Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway. Cancer Biology Therapy, 6 (12), 1944-1950. doi: 10.4161/cbt.6.12.4975 |
|
2007 Journal Article Treatment of peritoneal dialysis-associated peritonitis: A systematic review of randomized controlled trialsWiggins, Kathryn J., Johnson, David W., Craig, Jonathan C. and Strippoli, Giovanni F. M. (2007). Treatment of peritoneal dialysis-associated peritonitis: A systematic review of randomized controlled trials. American Journal of Kidney Diseases, 50 (6), 967-988. doi: 10.1053/j.ajkd.2007.08.015 |
|
2007 Conference Publication Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patientsMollee, Peter, Hourigan, Matthew, Johnson, David, Jones, Mark, Isbel, Nikki, Hawley, Carmel, Marlton, Paula, Gandhi, Maher, Campbell, Scott and Gill, Devinder (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA USA, 8-11 December 2007. Washington, DC USA: American Society of Hematology. |
|
2007 Journal Article Is the declining use of long-term peritoneal dialysis justified by outcome data?Khawar, Osman, Kalantar-Zadeh, Kamyar, Lo, Wai Kei, Johnson, David and Mehrotra, Mehrotra, Rajnish (2007). Is the declining use of long-term peritoneal dialysis justified by outcome data?. American Society of Nephrology, 2 (6), 1317-1328. doi: 10.2215/CJN.02550607 |
|
2007 Journal Article Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations (Position paper)Mathew, Timothy H., Johnson, David W. and Jones, Graham R. D. (2007). Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations (Position paper). Medical Journal of Australia, 187 (8), 459-463. doi: 10.5694/j.1326-5377.2007.tb01357.x |
|
2007 Journal Article High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysisWiggins, Kathryn J., McDonald, Stephen P., Brown, Fiona G., Rosman, Johan B. and Johnson, David W. (2007). High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrology, Dialysis, Transplantation, 22 (10), 3005-3012. doi: 10.1093/ndt/gfm324 |
|
2007 Journal Article Cardiovascular disease in patients with chronic kidney diseaseKaisar, M., Isbel, N. and Johnson, D. W. (2007). Cardiovascular disease in patients with chronic kidney disease. Minerva Urologica e Nefrologica, 59 (3), 281-297. |
|
2007 Journal Article Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activationVesey, David A., Kruger, Wade A., Poronnik, Philip, Gobe, Glenda C. and Johnson, David W. (2007). Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation. American Journal of Physiology: Renal Physiology, 293 (5), F1441-F1449. doi: 10.1152/ajprenal.00088.2007 |
|
2007 Journal Article Erthropoiesis-stimulating agent hyporesponsivenessJohnson, David W., Pollock, Carol A. and MacDougall, Iain C. (2007). Erthropoiesis-stimulating agent hyporesponsiveness. Nephrology, 12 (4), 321-330. doi: 10.1111/j.1440-1797.2007.00810.x |
|
2007 Journal Article Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of insulin-like growth factor binding protein-3 levelsCheung, Catherine W., Taylor, Paul J., Kirkpatrick, Carl M.J., Vesey, David A., Gobe, Glenda C., Winterford, Clay, Nicol, David L. and Johnson, David W. (2007). Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of insulin-like growth factor binding protein-3 levels. BJU International, 100 (2), 438-444. doi: 10.1111/j.1464-410X.2007.07012.x |
|
2007 Journal Article Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modificationJohnson, David W., Armstrong, Kirsten, Campbell, Scott B., Mudge, David W., Hawley, Carmel M., Coombes, Jeff S., Prins, Johannes B. and Isbel, Nicole M. (2007). Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology, 12 (4), 391-398. doi: 10.1111/j.1440-1797.2007.00804.x |
|
2007 Journal Article Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapiesYang, Tao, Vesey, David A., Johnson, David W., Wei, Ming Q. and Gobe, Glenda C. (2007). Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies. Translational Research, 150 (1), 40-50. doi: 10.1016/j.trsl.2007.01.006 |
|
2007 Journal Article Managing chronic kidney diseaseJohnson, David W. and Mathew, Timothy (2007). Managing chronic kidney disease. Medicine Today, 8 (7), 37-45. |
